IMMUNOBIOTICS AND THEIR EFFECT ON THE HUMAN IMMUNE SYSTEM IN HEALTH AND DISEASE

Main Article Content

Authors

S.A. Starovoitova

National University of Food Technologies, 68, Vladimirskaya str., Kiev, 0160, Ukraine

A.V. Karpov

National University of Food Technologies, 68, Vladimirskaya str., Kiev, 0160, Ukraine

Abstract

This article summarizes previous studies investigating the influence of the microbiota on the immune system in health and disease. The main stages of formation of the human intestinal microflora and related factors, as well as its normal physiological functions are discussed. The diseases associated with disruption of the microbiota, in which the use of probiotics results in immunological disorders of varying nature and severity is also discussed. Moreover, we outline the mechanisms that regulate the diversification of immune responses to pathogenic and commensal microorganisms. The effects of normal flora microorganisms on innate and adaptive immunity are characterized. In addition, human inflammatory diseases associated with microbiota disorders are described. The biological properties of probiotics are reviewed in the context of their modulatory effect on the inflammatory response. Accordingly, the immunomodulatory potential of probiotic microorganisms is analysed. In conclusion, this article offers recommendations on strategies for effective application of the immunomodulatory activity of probiotic microorganisms and probiotics.

Keywords

gut microbiota, immunomodulation, immunobiotics, inflammation, probiotic functions

Article Details

References

Petschow B., Doré J., Hibberd P. et al. Probiotics, prebiotics, and the host microbiome: the science of translation. Ann. N. Y. Acad. Sci, 2013, vol. 1306, pp. 1-17. PMID:424266656.

King S., Glanville J., Sanders M.E., Fitzgerald A., Varley D. Effectiveness of probiotics on the duration of illness in healthy children and adults who develop common acute respiratory infectious conditions: a systematic review and meta-analysis, 2014, vol. 112, no. 1, pp. 41-54. PMID:24780623. DOI: 10.1017/S0007114514000075.

Vasile N., Ghindea R., Vassu T. Probiotics- an alternative treatment for various diseases. Roum. Arch. Microbiol. Immunol, 2011, vol. 70, no. 2, pp. 54-59. PMID: 22106509.

Długońska H., Grzybowski M. Personalized vaccination? II. The role of natural microbiota in a vaccine-induced immunity. Wiad. Parazytol, 2011, vol. 57, no. 2, pp. 71-76. PMID: 21682089.

Starovoitova S.A., Babenko L.P., Timoshok N.A. et al. Cholesterol-lowering activity of lactic acid bacteria probiotic strains in vivo. Microbiol. Z, 2012, vol. 74, no. 3, pp.78-85. PMID: 22830201.

Duca F.A., Lam T.K. Gut microbiota, nutrient sensing and energy balance. Diabetes Obes. Metab, 2014, vol. 16, suppl. 1, pp. 68-76. PMID: 25200299.

Devaraj S., Hemarajata P., Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin. Chem, 2013, vol. 59, no. 4, pp. 617-628. PMID: 23401286.

Weng M., Walker W.A. The role of gut microbiota in programming the immune phenotype. J. Dev. Orig. Health Dis, 2013, vol. 4, no. 3, pp. 203-214. PMID: 24353893. DOI: 0.1017/S2040174412000712.

Chen X., D'Souza R., Hong S.T. The role of gut microbiota in the gut-brain axis: current challenges and perspectives. Prot. Cell, 2013, vol. 4, no. 6, pp. 403-414. PMID: 23686721. DOI 10.1007/s13238-013-3017-x.

Cerf-Bensussan N., Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat. Rev. Immunol, 2010, vol. 10, no. 10, pp. 35-744. PMID: 20865020.

Kuwahara T., Ogura Y., Oshima K. et al. The lifestyle of the segmented filamentous bacterium: a non-culturable gut-associated immunostimulating microbe inferred by whole-genome sequencing. DNA Res, 2011, vol. 18, no. 4, pp. 291-303. PMID: 21791478.

Jonsson H. Segmented filamentous bacteria in human ileostomy samples after high-fiber intake. FEMS Microbiol. Lett, 2013, vol. 342, no. 1, pp. 24-29. PMID: 23406300. DOI: 10.1111/1574-6968.12103.

O'Flaherty S., Saulnier D.M., Pot B., Versalovic J. How can probiotics and prebiotics impact mucosal immunity? Gut Microbes, 2010, vol. 1, no. 5, pp. 293-300. PMID: 21327037.

Matamoros S., Gras-Leguen C., Le Vacon F. et al. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol, 2013, vol. 21, no. 4, pp. 167-173. PMID: 23332725. DOI: 10.1016/j.tim.2012.12.001.

Yatsunenko T., Rey F.E., Manary M.J. et al. Human gut microbiome viewed across age and geography. Nature, 2012, vol. 486, no 7402, pp. 222-227. PMID: 22699611. DOI: 10.1038/nature11053.

Bushman F.D., Lewis J.D., Wu G.D. Diet, gut enterotypes and health: is there a link? Nestle Nutr. Inst. Workshop Ser, 2013, vol. 77, pp. 65-73. PMID: 24107497. DOI: 10.1159/000351385.

de Kivit S., Tobin M.C., Forsyth C.B. et al. Regulation of Intestinal Immune Responses through TLR Activation: Implications for Pro- and Prebiotics. Front. Immunol, 2014, vol. 5, pp. 60. PMID: 24600450. DOI: 10.3389/fimmu.2014.00060.

Tourneur E., Chassin C. Neonatal immune adaptation of the gut and its role during infections. Clin. Dev. Immunol, 2013, vol. 2013, id. 270301. Crossref.

Corridoni D., Arseneau K.O., Cifone M.G., Cominelli F. The dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation. Front. Immunol, 2014, vol. 5, id. 317. PMID: 25071778.

Villena J., Kitazawa H. Modulation of Intestinal TLR4-Inflammatory Signaling Pathways by Probiotic Microorganisms: Lessons Learned from Lactobacillus jensenii TL2937. Front. Immunol, 2014, vol. 4, id. 512. PMID: 24459463. DOI: 0.3389/fimmu.2013.00512.

Habil N., Al-Murrani W., Beal J., Foey A.D. Probiotic bacterial strains differentially modulate macrophage cytokine production in a strain-dependent and cell subset-specific manner. Benef. Microbes, 2011, vol. 2, no. 4, pp. 283-293. PMID: 22146688. DOI: 10.3920/BM2011.0027.

Kamdar K., Nguyen V., De Paolo R.W. Toll-like receptor signaling and regulation of intestinal immunity. Virulence, 2013, vol. 4, no. 3, pp. 207-212. PMID: 23334153. DOI: 10.4161/viru.23354.

Everard A., Cani P.D. Diabetes, obesity and gut microbiota. Best Pract. Res. Clin. Gastroenterol, 2013, vol. 27, no. 1, pp. 73-83. PMID: 23768554. DOI: 10.1016/j.bpg.2013.03.007.

Kim S., Kim J.H., Park B.O., Kwak Y.S. Perspectives on the therapeutic potential of short-chain fatty acid receptors. BMB Rep, 2014, vol. 47, no. 3, pp. 173-178. PMID:24499669.

Albenberg L.G., Wu G.D. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology, 2014, vol. 146, no. 6, pp. 1564–1572. PMID: 24503132. DOI: 10.1053/j.gastro.2014.01.058.

De Palma G., Collins S.M., Bercik P., Verdu E.F. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J. Physiol, 2014, vol. 592, pt. 14, pp. 2989-2997. PMID: 24756641. DOI: 10.1113/jphysiol.2014.273995.

Lee K.N., Lee O.Y. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J. Gastroenterol, 2014, vol. 20, no. 27, pp. 8886-8897. PMID: 25083061. DOI: 10.3748/wjg.v20.i27.8886.

Shen J., Obin M.S., Zhao L. The gut microbiota, obesity and insulin resistance. Mol. Aspects Med, 2013, vol. 34, no. 1, pp. 39-58. PMID: 23159341. DOI: 10.1016/j.mam.2012.11.001.

Winter S.E., Lopez C.A., Bäumler A.J. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep, 2013, vol. 14, no. 4, pp. 319-327. PMID: 23478337. DOI: 0.1038/embor.2013.27.

Silvestri C., Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell. Metab, 2013, vol. 17, no. 4, pp. 475-490. PMID: 23562074. DOI: 10.1016/j.cmet.2013.03.001.

Kelder T., Stroeve J.H., Bijlsma S., Radonjic M., Roeselers G. Correlation network analysis reveals relationships between diet-induced changes in human gut microbiota and metabolic health. Nutr. Diabetes, 2014, vol. 4, id. 122. PMID: 24979151. DOI: 10.1038/nutd.2014.18.

Yokota A., Fukiya S., Islam K.B. et al. Is bile acid a determinant of the gut microbiota on a high-fat diet? Gut Microbes, 2012, vol. 3, no. 5, pp. 455-459. DOI: 10.4161/gmic.21216.

Schnabl B., Brenner D.A. Interactions between the intestinal microbiome and liver diseases. Gastroenterology, 2014, vol. 146, no. 6, pp. 1513-1524. PMID: 24440671. DOI: 10.1053/j.gastro.2014.01.020.

Zhu Y., Michelle Luo T., Jobin C., Young H.A. Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett, 2011, vol. 309, no. 2, pp. 119-127. PMID: 21741763. DOI: 10.1016/j.canlet.2011.06.004.

Noval Rivas M., Burton O.T., Wise P. et al. A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis. J. Allergy Clin. Immunol, 2013, vol. 131, no. 1, pp. 201-212. PMID: 23201093. DOI: 10.1016/j.jaci.2012.10.026.

Villena J., Chiba E., Tomosada Y. et al. Orally administered Lactobacillus rhamnosus modulates the respiratory immune response triggered by the viral pathogen-associated molecular pattern poly(I:C). BMC Immunol, 2012, vol. 13, id 53. DOI:10.1186/1471-2172-13-53.

Rose M.A., Stieglitz F., Köksal A., Schubert R., Schulze J., Zielen S. Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk. Clin. Exp. Allergy, 2010, vol. 40, no. 9, pp. 1398-1405. PMID: 20604800. DOI: 10.1111/j.1365-2222.2010.03560.x.

Yeganegi M., Leung C.G., Martins A. et al. Lactobacillus rhamnosus GR-1-induced IL-10 production in human placental trophoblast cells involves activation of JAK/STAT and MAPK pathways. Reprod. Sci, 2010, vol. 17, no. 11, pp. 1043-1051. PMID: 20858906. DOI: 10.1177/1933719110377237.

Shida K., Nanno M., Nagata S. Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes, 2011, vol. 2, no. 2, pp. 109-114. PMID: 21637028.

Vieira A.T., Teixeira M.M., Martins F.S. The role of probiotics and prebiotics in inducing gut immunity. Front. Immunol, 2013, vol. 4, id. 445. DOI: 10.3389/fimmu.2013.00445.

Groeger D., O'Mahony L., Murphy E. F. et al. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes, 2013, vol. 4, no. 4, pp. 325-339. PMID: 23842110. DOI: 10.4161/gmic.25487.

Konieczna P., Akdis C.A., Quigley E.M., Shanahan F., O’Mahony L. Portrait of an immunoregulatory Bifidobacterium. Gut Microbes, 2012, vol. 3, no. 3, pp. 261-266. PMID: 22572827. DOI: 10.4161/gmic.20358.

Scott K.P., Martin J.C., Duncan S.H., Flint H.J. Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbiol. Ecol, 2014, vol. 87, no. 1, pp. 30-40. PMID: 23909466. DOI: 10.1111/1574-6941.12186.

Roelofsen H., Priebe M.G., Vonk R.J. The interaction of short-chain fatty acids with adipose tissue: relevance for prevention of type 2 diabetes. Benef. Microbes, 2010, vol. 1, no. 4, pp. 433-437. PMID: 21831781. DOI: 10.3920/BM2010.0028.

Bassaganya-Riera J., Viladomiu M., Pedragosa M. et al. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitis. PLoS One, 2012, vol. 7, no. 2, id. 31238. PMID: 22363592, DOI: 10.1371/journal.pone.0031238.

Thomas C.M., Hong T., van Pijkeren J.P. et al. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One, 2012, vol. 7, no. 2, id. 31951. PMID: 22384111. DOI: 10.1371/journal.pone.0031951.

Eberl G., Boneca I.G. Bacteria and MAMP-induced morphogenesis of the immune system. Curr. Opin. Immunol, 2010, vol. 22, no. 4, pp. 448-454. PMID: 20580214. DOI: 10.1016/j.coi.2010.06.002.

Takagi T., Inada Y., Naito Y. Circadian rhythm and inflammatory bowel disease. Nihon. Rinsho, 2013, vol. 71, no. 12, pp. 2165-2170. PMID: 24437273.

Isidro R.A., Bonilla F.J., Pagan H. et al. The Probiotic Mixture VSL#3 Alters the Morphology and Secretion Profile of Both Polarized and Unpolarized Human Macrophages in a Polarization-Dependent Manner. J. Clin. Cell. Immunol, 2014, vol. 5, no. 3, pp. 10002-10027. DOI: 10.4172/2155-9899.1000227.

Kant R., de Vos W.M., Palva A., Satokari R. Immunostimulatory CpG motifs in the genomes of gut bacteria and their role in human health and disease. J. Med. Microbiol, 2014, vol. 63, pt 2, pp. 293-308. PMID: 24255136. DOI: 10.1099/jmm.0.064220-0.